Scholtes Bret 4
4 · Guardion Health Sciences, Inc. · Filed Sep 1, 2021
Insider Transaction Report
Form 4
Scholtes Bret
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Purchase
Common stock
2021-08-31$1.23/sh+5,500$6,760→ 179,484 total - Purchase
Common stock
2021-08-30$1.26/sh+4,500$5,656→ 173,984 total
Footnotes (2)
- [F1]This sales price reflects a weighted average of multiple prices ranging from $1.245 to $1.27. Full information regarding the number of shares sold at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request.
- [F2]This sales price reflects a weighted average of multiple prices ranging from $1.21 to $1.25. Full information regarding the number of shares sold at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request.